export const CATEGORIES = [
  {
    name: 'Body Composition',
    slug: 'body-composition',
    description: 'Peptides that support muscle growth, fat loss, and body recomposition through growth hormone pathways.',
    icon: 'üí™',
    color: '#3b82f6',
  },
  {
    name: 'Weight Management',
    slug: 'weight-management',
    description: 'GLP-1 agonists and metabolic peptides for appetite regulation and fat loss.',
    icon: '‚öñÔ∏è',
    color: '#10b981',
  },
  {
    name: 'Healing & Recovery',
    slug: 'healing-recovery',
    description: 'Peptides that accelerate tissue repair, reduce inflammation, and support injury recovery.',
    icon: 'ü©π',
    color: '#f59e0b',
  },
  {
    name: 'Anti-Aging & Longevity',
    slug: 'anti-aging',
    description: 'Peptides studied for their effects on aging, telomere length, and longevity.',
    icon: '‚è≥',
    color: '#8b5cf6',
  },
  {
    name: 'Tanning',
    slug: 'tanning',
    description: 'Melanocortin peptides that stimulate melanin production for skin pigmentation.',
    icon: '‚òÄÔ∏è',
    color: '#f97316',
  },
  {
    name: 'Cognitive & Nootropic',
    slug: 'cognitive',
    description: 'Peptides that enhance cognitive function, memory, focus, and neuroprotection.',
    icon: 'üß†',
    color: '#06b6d4',
  },
  {
    name: 'Immune Support',
    slug: 'immune-support',
    description: 'Peptides that modulate and boost immune function and antimicrobial defense.',
    icon: 'üõ°Ô∏è',
    color: '#84cc16',
  },
  {
    name: 'Sexual Health',
    slug: 'sexual-health',
    description: 'Peptides that support sexual function, libido, and reproductive health.',
    icon: '‚ù§Ô∏è',
    color: '#ec4899',
  },
  {
    name: 'Experimental',
    slug: 'experimental',
    description: 'Emerging peptides in early-stage research with promising but unconfirmed benefits.',
    icon: 'üî¨',
    color: '#6b7280',
  },
]

export const PEPTIDES = [
  // BODY COMPOSITION
  {
    name: 'Ipamorelin',
    slug: 'ipamorelin',
    aliases: ['Ipamorelin acetate', 'NNC 26-0161'],
    category_slug: 'body-composition',
    summary: 'A selective growth hormone secretagogue and ghrelin mimetic that stimulates GH release without significantly elevating cortisol or prolactin. One of the cleanest and most widely used peptides for body recomposition.',
    mechanism: 'Ipamorelin is a pentapeptide that selectively binds to the growth hormone secretagogue receptor (GHS-R), stimulating the pituitary gland to release growth hormone in a pulsatile, physiological manner. Unlike other GHRPs, it does not significantly elevate cortisol, prolactin, or ACTH, making it one of the most selective GH-releasing peptides available.',
    benefits: [
      'Increases growth hormone and IGF-1 levels',
      'Promotes lean muscle mass development',
      'Supports fat loss and body recomposition',
      'Improves sleep quality and recovery',
      'Enhances bone density over time',
      'Minimal cortisol or prolactin elevation compared to other GHRPs',
    ],
    side_effects: [
      'Mild headaches (often from GH surge)',
      'Water retention, especially early in use',
      'Mild fatigue or lethargy',
      'Potential numbness or tingling in extremities',
      'Flushing at injection site',
    ],
    dosage_info: {
      min_dose: 200,
      max_dose: 300,
      unit: 'mcg',
      frequency: '1‚Äì3x daily, ideally before bed or post-workout',
      notes: 'Commonly stacked with CJC-1295. 8‚Äì12 week cycles recommended.',
      weight_based: false,
    },
    cycle_length: '8‚Äì12 weeks',
    stack_with: ['cjc-1295', 'sermorelin'],
    research_status: 'research_only',
    administration_routes: ['subcutaneous injection'],
    molecular_formula: 'C38H49N9O5',
    half_life: '2 hours',
  },
  {
    name: 'CJC-1295',
    slug: 'cjc-1295',
    aliases: ['CJC-1295 DAC', 'Modified GRF 1-29', 'Mod GRF 1-29', 'CJC1295'],
    category_slug: 'body-composition',
    summary: 'A synthetic analog of growth hormone-releasing hormone (GHRH) that extends the half-life of endogenous GHRH. One of the most popular peptides for muscle growth and fat loss when stacked with a GHRP like Ipamorelin.',
    mechanism: 'CJC-1295 is a 30-amino acid GHRH analog modified with a Drug Affinity Complex (DAC) to extend its half-life from minutes to days. It binds to GHRH receptors on the pituitary gland, stimulating pulsatile GH secretion and subsequently increasing IGF-1. The DAC version has a half-life of approximately 6‚Äì8 days, allowing for once or twice-weekly dosing.',
    benefits: [
      'Sustained elevation of GH and IGF-1 levels',
      'Increased lean muscle mass',
      'Enhanced fat metabolism and lipolysis',
      'Improved recovery from training and injury',
      'Better sleep quality and REM sleep',
      'Improved skin elasticity and collagen synthesis',
      'Potential anti-aging effects',
    ],
    side_effects: [
      'Water retention',
      'Mild fatigue',
      'Headaches',
      'Flushing',
      'Joint pain at high doses',
      'Potential insulin resistance with prolonged use',
    ],
    dosage_info: {
      min_dose: 1000,
      max_dose: 2000,
      unit: 'mcg',
      frequency: 'Once or twice weekly (DAC version)',
      notes: 'Non-DAC version (Mod GRF 1-29) dosed at 100‚Äì200 mcg per injection, 1‚Äì3x daily. Stack with Ipamorelin or GHRP-6.',
      weight_based: false,
    },
    cycle_length: '8‚Äì12 weeks',
    stack_with: ['ipamorelin', 'ghrp-6', 'ghrp-2'],
    research_status: 'research_only',
    administration_routes: ['subcutaneous injection'],
    molecular_formula: 'C152H252N44O42',
    half_life: '6‚Äì8 days (DAC), 30 minutes (non-DAC)',
  },
  {
    name: 'Sermorelin',
    slug: 'sermorelin',
    aliases: ['GRF 1-29 NH2', 'GHRH 1-29', 'Geref'],
    category_slug: 'body-composition',
    summary: 'A 29-amino acid synthetic analog of endogenous GHRH that stimulates natural GH production. Clinically used for GH deficiency and widely used in anti-aging medicine as a safer alternative to exogenous HGH.',
    mechanism: 'Sermorelin consists of the first 29 amino acids of GHRH and directly stimulates the anterior pituitary to secrete endogenous growth hormone. It works via a feedback mechanism that prevents GH levels from rising too high, making it safer than direct HGH administration. It restores youthful GH secretion patterns.',
    benefits: [
      'Restores natural GH secretion patterns',
      'Supports lean muscle growth and maintenance',
      'Promotes fat reduction, especially visceral fat',
      'Improves sleep quality and circadian rhythm',
      'Enhances immune function',
      'Thicker hair and stronger nails',
      'Improved wound healing',
      'Cardiovascular health support',
    ],
    side_effects: [
      'Injection site reactions (redness, swelling)',
      'Flushing',
      'Headaches',
      'Mild nausea',
      'Dizziness',
    ],
    dosage_info: {
      min_dose: 0.2,
      max_dose: 0.3,
      unit: 'mg',
      frequency: 'Once daily at bedtime (subcutaneous)',
      notes: 'Best administered at night to align with natural GH pulsatility. Cycles up to 3‚Äì6 months.',
      weight_based: false,
    },
    cycle_length: '3‚Äì6 months',
    stack_with: ['ipamorelin', 'cjc-1295'],
    research_status: 'prescription',
    administration_routes: ['subcutaneous injection'],
    molecular_formula: 'C149H246N44O42S',
    half_life: '10‚Äì20 minutes',
  },
  {
    name: 'Tesamorelin',
    slug: 'tesamorelin',
    aliases: ['Egrifta', 'TH9507'],
    category_slug: 'body-composition',
    summary: 'An FDA-approved synthetic GHRH analog originally developed to treat HIV-associated lipodystrophy. Highly effective at reducing visceral adipose tissue and is increasingly used in anti-aging and metabolic medicine.',
    mechanism: 'Tesamorelin is a 44-amino acid synthetic GHRH analog that stabilizes GHRH against enzymatic degradation. It binds GHRH receptors on the pituitary, increasing GH and subsequently IGF-1. Its primary clinical action is lipolysis of visceral adipose tissue, with studies showing average 17% reductions in visceral fat.',
    benefits: [
      'Significant reduction in visceral fat (average 17% in clinical trials)',
      'Improved metabolic markers (triglycerides, HDL)',
      'Increased IGF-1 and GH levels',
      'Potential cognitive benefits (under investigation)',
      'FDA-approved for HIV lipodystrophy',
      'Improved body composition',
    ],
    side_effects: [
      'Injection site reactions',
      'Peripheral edema (water retention)',
      'Arthralgia (joint pain)',
      'Myalgia (muscle pain)',
      'Potential glucose intolerance',
      'Carpal tunnel symptoms',
    ],
    dosage_info: {
      min_dose: 1,
      max_dose: 2,
      unit: 'mg',
      frequency: 'Once daily subcutaneous injection',
      notes: 'Clinical dose is 2mg/day. Research cycles typically 4‚Äì12 weeks.',
      weight_based: false,
    },
    cycle_length: '4‚Äì12 weeks',
    stack_with: ['ipamorelin', 'bpc-157'],
    research_status: 'fda_approved',
    administration_routes: ['subcutaneous injection'],
    molecular_formula: 'C221H366N72O67S',
    half_life: '26 minutes',
  },
  {
    name: 'MK-677 (Ibutamoren)',
    slug: 'mk-677',
    aliases: ['Ibutamoren', 'MK677', 'Nutrobal', 'L-163,191'],
    category_slug: 'body-composition',
    summary: 'A non-peptide, orally active growth hormone secretagogue that mimics ghrelin, significantly elevating GH and IGF-1 levels. Unique in being orally bioavailable, making it convenient compared to injectable peptides.',
    mechanism: 'MK-677 is a selective ghrelin receptor agonist (GHS-R1a) that stimulates the pituitary gland to release growth hormone without affecting cortisol. It increases both GH pulse amplitude and IGF-1 levels. Despite being orally administered, its effects rival injectable GH secretagogues.',
    benefits: [
      'Significantly increases GH and IGF-1 levels',
      'Promotes lean muscle mass and strength',
      'Enhances fat metabolism',
      'Markedly improves sleep quality (especially REM)',
      'Increases appetite (useful for lean bulking)',
      'Potential bone density improvements',
      'Improved skin and hair quality',
    ],
    side_effects: [
      'Increased appetite (significant)',
      'Water retention and bloating',
      'Lethargy or fatigue',
      'Potential insulin resistance with chronic use',
      'Increased fasting glucose',
      'Tingling in hands/feet',
      'Joint pain at high doses',
    ],
    dosage_info: {
      min_dose: 10,
      max_dose: 25,
      unit: 'mg',
      frequency: 'Once daily, oral (typically at night)',
      notes: 'Can be run continuously for 4‚Äì6 months. Lower doses (10‚Äì15mg) minimize side effects.',
      weight_based: false,
    },
    cycle_length: '3‚Äì6 months',
    stack_with: ['ipamorelin', 'cjc-1295', 'bpc-157'],
    research_status: 'research_only',
    administration_routes: ['oral'],
    molecular_formula: 'C27H36N4O5S',
    half_life: '24 hours',
  },
  {
    name: 'Hexarelin',
    slug: 'hexarelin',
    aliases: ['Examorelin', 'EP 23905', 'MF-6003'],
    category_slug: 'body-composition',
    summary: 'A synthetic hexapeptide GHRP with the highest GH-releasing potency among the GHRP family. Notable for both its muscle-building effects and documented cardiovascular benefits.',
    mechanism: 'Hexarelin is a 6-amino acid synthetic peptide that binds both the GHS-R receptor and the CD36 scavenger receptor. It stimulates strong GH release from the pituitary and has direct cardioprotective effects independent of GH secretion, making it unique among GHRPs.',
    benefits: [
      'Potent GH release (strongest among GHRPs)',
      'Increased lean muscle mass and strength',
      'Fat loss and body recomposition',
      'Improved bone density',
      'Enhanced collagen production',
      'Direct cardioprotective effects (unique among GHRPs)',
      'Accelerated healing',
    ],
    side_effects: [
      'Elevated cortisol and prolactin (more than other GHRPs)',
      'Fatigue and lethargy',
      'Water retention',
      'Potential insulin resistance',
      'Desensitization with prolonged continuous use',
      'Headaches',
    ],
    dosage_info: {
      min_dose: 200,
      max_dose: 300,
      unit: 'mcg',
      frequency: '1‚Äì3x daily subcutaneous injection',
      notes: 'Cycle 8‚Äì12 weeks then take a break to avoid desensitization. Stack with GHRH peptide for synergy.',
      weight_based: false,
    },
    cycle_length: '8‚Äì12 weeks',
    stack_with: ['cjc-1295', 'sermorelin'],
    research_status: 'research_only',
    administration_routes: ['subcutaneous injection'],
    molecular_formula: 'C47H58N12O6',
    half_life: '30‚Äì70 minutes',
  },
  {
    name: 'GHRP-6',
    slug: 'ghrp-6',
    aliases: ['Growth Hormone Releasing Peptide-6', 'GHRP6', 'SK&F-110679'],
    category_slug: 'body-composition',
    summary: 'One of the first synthetic GHRPs developed, GHRP-6 is a potent GH secretagogue that also significantly stimulates appetite through ghrelin receptor activation. Widely used for muscle building and recovery.',
    mechanism: 'GHRP-6 is a hexapeptide that acts on GHS-R receptors to stimulate GH release from the anterior pituitary. It also acts as a functional analog of ghrelin, significantly increasing appetite ‚Äî a feature that distinguishes it from other GHRPs. Synergistically effective when combined with GHRH analogs.',
    benefits: [
      'Potent GH release',
      'Significant increase in lean muscle mass',
      'Enhanced recovery and tissue repair',
      'Increased appetite (beneficial for hard gainers)',
      'IGF-1 elevation',
      'Anti-inflammatory properties',
    ],
    side_effects: [
      'Strong hunger/appetite increase (most notable side effect)',
      'Elevated cortisol and prolactin',
      'Water retention',
      'Lethargy',
      'Potential desensitization',
    ],
    dosage_info: {
      min_dose: 100,
      max_dose: 300,
      unit: 'mcg',
      frequency: '1‚Äì3x daily, 30‚Äì45 min before meals',
      notes: 'The appetite-stimulating effect is dose-dependent. Stack with CJC-1295 for synergistic GH release.',
      weight_based: false,
    },
    cycle_length: '8‚Äì12 weeks',
    stack_with: ['cjc-1295', 'mod-grf-1-29'],
    research_status: 'research_only',
    administration_routes: ['subcutaneous injection', 'intranasal'],
    molecular_formula: 'C46H56N12O6',
    half_life: '15‚Äì60 minutes',
  },
  {
    name: 'GHRP-2',
    slug: 'ghrp-2',
    aliases: ['Growth Hormone Releasing Peptide-2', 'GHRP2', 'Pralmorelin', 'KP-102'],
    category_slug: 'body-composition',
    summary: 'A second-generation GHRP with high GH-releasing potency and a cleaner side effect profile than GHRP-6. Less appetite stimulation makes it preferable for those focused on body recomposition.',
    mechanism: 'GHRP-2 is a synthetic hexapeptide that acts as a potent GHS-R agonist. It stimulates pulsatile GH release through both pituitary and hypothalamic mechanisms. While still elevating cortisol and prolactin, the effect is less pronounced than GHRP-6, and appetite stimulation is minimal.',
    benefits: [
      'Strong GH release with less cortisol elevation than GHRP-6',
      'Muscle growth and recomposition',
      'Fat loss',
      'Minimal appetite stimulation',
      'Improved recovery',
      'IGF-1 increase',
    ],
    side_effects: [
      'Cortisol and prolactin elevation (moderate)',
      'Water retention',
      'Headaches',
      'Mild fatigue',
    ],
    dosage_info: {
      min_dose: 100,
      max_dose: 300,
      unit: 'mcg',
      frequency: '1‚Äì3x daily',
      notes: 'Better choice than GHRP-6 when appetite stimulation is unwanted. Stack with a GHRH peptide.',
      weight_based: false,
    },
    cycle_length: '8‚Äì12 weeks',
    stack_with: ['cjc-1295', 'sermorelin'],
    research_status: 'research_only',
    administration_routes: ['subcutaneous injection'],
    molecular_formula: 'C45H55N9O6',
    half_life: '15‚Äì60 minutes',
  },
  {
    name: 'IGF-1 LR3',
    slug: 'igf-1-lr3',
    aliases: ['IGF-1', 'Insulin-Like Growth Factor 1', 'Long R3 IGF-1', 'IGF1 LR3'],
    category_slug: 'body-composition',
    summary: 'A long-acting analog of IGF-1 with a modified arginine substitution that extends its half-life from minutes to over 20 hours. Directly stimulates muscle protein synthesis independent of GH.',
    mechanism: 'IGF-1 LR3 is a 83-amino acid analog of endogenous IGF-1 with an N-terminal extension that reduces its affinity for IGF-binding proteins (IGFBPs), dramatically extending its half-life. It directly binds IGF-1 receptors in muscle, liver, and other tissues to stimulate protein synthesis, glucose uptake, and nitrogen retention.',
    benefits: [
      'Direct muscle protein synthesis stimulation (independent of GH)',
      'Significant lean muscle mass increases',
      'Enhanced fat oxidation',
      'Improved nitrogen retention',
      'Accelerated recovery from training',
      'Anti-catabolic effects during caloric restriction',
      'Potential anti-aging effects',
    ],
    side_effects: [
      'Hypoglycemia (most serious risk)',
      'Stomach discomfort and digestive issues',
      'Joint swelling',
      'Jaw pain',
      'Potential organ growth with excessive dosing',
      'Water retention',
    ],
    dosage_info: {
      min_dose: 20,
      max_dose: 100,
      unit: 'mcg',
      frequency: 'Once daily post-workout',
      notes: 'Always administer with carbohydrates to prevent hypoglycemia. 2‚Äì4 week cycles with breaks.',
      weight_based: false,
    },
    cycle_length: '2‚Äì4 weeks',
    stack_with: ['cjc-1295', 'ipamorelin', 'tb-500'],
    research_status: 'research_only',
    administration_routes: ['subcutaneous injection', 'intramuscular injection'],
    molecular_formula: 'C400H625N111O115S9',
    half_life: '20‚Äì30 hours',
  },
  {
    name: 'MGF (Mechano Growth Factor)',
    slug: 'mgf',
    aliases: ['Mechano Growth Factor', 'IGF-1Ec', 'PEG-MGF'],
    category_slug: 'body-composition',
    summary: 'A splice variant of IGF-1 that is released in muscle fibers in response to mechanical damage. Activates muscle satellite cells to initiate repair and hypertrophy, making it critical for post-workout recovery.',
    mechanism: 'MGF is generated by alternative splicing of the IGF-1 gene and differs from IGF-1 LR3 in its receptor binding specificity. It activates muscle stem cells (satellite cells) to proliferate and fuse with existing muscle fibers, initiating the hypertrophic response. Its expression naturally declines with age.',
    benefits: [
      'Activates muscle satellite cells for repair and growth',
      'Maximizes post-workout hypertrophy',
      'Rapid local tissue repair',
      'Supports muscle maintenance during caloric restriction',
      'Synergistic with IGF-1 LR3',
    ],
    side_effects: [
      'Hypoglycemia risk',
      'Local muscle swelling at injection site',
      'Joint discomfort',
    ],
    dosage_info: {
      min_dose: 100,
      max_dose: 200,
      unit: 'mcg',
      frequency: 'Post-workout, localized injection to worked muscle groups',
      notes: 'Best used immediately post-workout. PEG-MGF has extended half-life for systemic administration. 4‚Äì6 week cycles.',
      weight_based: false,
    },
    cycle_length: '4‚Äì6 weeks',
    stack_with: ['igf-1-lr3', 'cjc-1295'],
    research_status: 'research_only',
    administration_routes: ['intramuscular injection'],
    molecular_formula: null,
    half_life: 'Minutes (MGF), 30+ hours (PEG-MGF)',
  },
  {
    name: 'Follistatin-344',
    slug: 'follistatin-344',
    aliases: ['FST-344', 'Follistatin 344'],
    category_slug: 'body-composition',
    summary: 'A naturally occurring protein that inhibits myostatin and activin, effectively removing the biological ceiling on muscle growth. Produces dramatic increases in lean mass in animal studies.',
    mechanism: 'Follistatin-344 is a 323-amino acid glycoprotein that acts as a natural myostatin inhibitor. Myostatin limits muscle growth, and by blocking it, Follistatin-344 effectively removes the genetic ceiling on muscle development. It also inhibits activin, which regulates FSH, adding reproductive and metabolic effects.',
    benefits: [
      'Removes myostatin-imposed ceiling on muscle growth',
      'Dramatic increases in lean muscle mass',
      'Increased bone density',
      'Enhanced endurance',
      'Anti-catabolic effects',
    ],
    side_effects: [
      'Potential joint weakness (tendons may not keep up with rapid muscle growth)',
      'Injection site irritation',
      'Elevated body temperature',
      'Limited long-term human safety data',
    ],
    dosage_info: {
      min_dose: 50,
      max_dose: 100,
      unit: 'mcg',
      frequency: 'Once daily',
      notes: 'Research cycles of 10‚Äì30 days. Very limited human data ‚Äî handle with caution.',
      weight_based: false,
    },
    cycle_length: '10‚Äì30 days',
    stack_with: ['igf-1-lr3', 'cjc-1295'],
    research_status: 'research_only',
    administration_routes: ['subcutaneous injection', 'intramuscular injection'],
    molecular_formula: null,
    half_life: null,
  },

  // WEIGHT MANAGEMENT
  {
    name: 'Semaglutide',
    slug: 'semaglutide',
    aliases: ['Ozempic', 'Wegovy', 'Rybelsus'],
    category_slug: 'weight-management',
    summary: 'An FDA-approved GLP-1 receptor agonist originally developed for type 2 diabetes that produces significant weight loss (average 14.9% body weight in clinical trials). One of the most clinically validated weight loss peptides available.',
    mechanism: 'Semaglutide is a 94% homologous analog of endogenous GLP-1 with extended half-life modifications. It activates GLP-1 receptors in the pancreas (stimulating insulin), brain (reducing appetite), and gastrointestinal tract (slowing gastric emptying). The resulting appetite suppression and reduced caloric intake drive substantial weight loss.',
    benefits: [
      'Average 14.9% body weight reduction in clinical trials',
      'Potent appetite suppression',
      'Blood glucose regulation',
      'Cardiovascular risk reduction (approved indication)',
      'Improved metabolic markers',
      'Reduced visceral fat',
      'Weekly dosing convenience',
    ],
    side_effects: [
      'Nausea (most common, especially early)',
      'Constipation or diarrhea',
      'Vomiting',
      'Abdominal pain',
      'Potential pancreatitis (rare)',
      'Potential thyroid C-cell tumors (in animal models)',
      'Muscle mass loss with rapid weight loss',
    ],
    dosage_info: {
      min_dose: 0.25,
      max_dose: 2.4,
      unit: 'mg',
      frequency: 'Once weekly subcutaneous injection',
      notes: 'Start at 0.25mg/week, titrate up over 16‚Äì20 weeks to target dose of 1‚Äì2.4mg. Rybelsus is oral (14mg/day).',
      weight_based: false,
    },
    cycle_length: 'Ongoing / chronic',
    stack_with: ['mk-677', 'bpc-157'],
    research_status: 'fda_approved',
    administration_routes: ['subcutaneous injection', 'oral'],
    molecular_formula: 'C187H291N45O59',
    half_life: '7 days',
  },
  {
    name: 'Tirzepatide',
    slug: 'tirzepatide',
    aliases: ['Mounjaro', 'Zepbound', 'LY3298176'],
    category_slug: 'weight-management',
    summary: 'A dual GLP-1 and GIP receptor agonist representing the next generation of metabolic peptides. Achieves greater weight loss than semaglutide in head-to-head trials, with average reductions of 20‚Äì22.5% body weight.',
    mechanism: 'Tirzepatide is a synthetic 39-amino acid peptide that acts as an agonist at both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors. The dual action provides synergistic metabolic effects: GLP-1 reduces appetite and GIP enhances the incretin effect and may directly promote fat oxidation. This dual agonism produces superior weight loss compared to GLP-1 alone.',
    benefits: [
      'Superior weight loss vs. semaglutide (20‚Äì22.5% body weight in trials)',
      'Dual GLP-1/GIP receptor activation',
      'Significant HbA1c reduction in type 2 diabetes',
      'Improved cardiovascular risk factors',
      'Reduced visceral adiposity',
      'Weekly dosing',
    ],
    side_effects: [
      'Nausea, vomiting, diarrhea',
      'Decreased appetite',
      'Constipation',
      'Potential pancreatitis',
      'Hypoglycemia (especially with insulin)',
      'Muscle mass reduction',
    ],
    dosage_info: {
      min_dose: 2.5,
      max_dose: 15,
      unit: 'mg',
      frequency: 'Once weekly subcutaneous injection',
      notes: 'Titrate from 2.5mg/week up by 2.5mg every 4 weeks to maximum 15mg. FDA-approved for T2D and obesity.',
      weight_based: false,
    },
    cycle_length: 'Ongoing / chronic',
    stack_with: ['bpc-157'],
    research_status: 'fda_approved',
    administration_routes: ['subcutaneous injection'],
    molecular_formula: 'C225H348N48O68',
    half_life: '5 days',
  },
  {
    name: 'Liraglutide',
    slug: 'liraglutide',
    aliases: ['Victoza', 'Saxenda'],
    category_slug: 'weight-management',
    summary: 'An FDA-approved once-daily GLP-1 receptor agonist for type 2 diabetes and weight management. Produces 5‚Äì8% average weight loss and has established cardiovascular safety data.',
    mechanism: 'Liraglutide is a 97% homologous GLP-1 analog with a fatty acid side chain that enables once-daily dosing via self-aggregation and albumin binding. It activates GLP-1 receptors throughout the body to slow gastric emptying, increase insulin secretion, and reduce glucagon levels, resulting in appetite reduction and weight loss.',
    benefits: [
      'FDA-approved for weight management (Saxenda)',
      'Reduces appetite and caloric intake',
      '5‚Äì8% average weight reduction',
      'Improved glycemic control',
      'Cardiovascular safety established',
      'Once-daily dosing',
    ],
    side_effects: [
      'Nausea (very common)',
      'Diarrhea',
      'Constipation',
      'Vomiting',
      'Injection site reactions',
      'Potential gallbladder disease',
    ],
    dosage_info: {
      min_dose: 0.6,
      max_dose: 3,
      unit: 'mg',
      frequency: 'Once daily subcutaneous injection',
      notes: 'Start at 0.6mg/day, titrate weekly to target of 1.8mg (diabetes) or 3mg (weight loss).',
      weight_based: false,
    },
    cycle_length: 'Ongoing / chronic',
    stack_with: [],
    research_status: 'fda_approved',
    administration_routes: ['subcutaneous injection'],
    molecular_formula: 'C172H265N43O51',
    half_life: '13 hours',
  },
  {
    name: 'AOD-9604 (HGH Fragment 176-191)',
    slug: 'aod-9604',
    aliases: ['AOD9604', 'HGH Fragment 176-191', 'Frag 176-191', 'HGH Frag'],
    category_slug: 'weight-management',
    summary: 'A synthetic fragment of the C-terminus of HGH (amino acids 176‚Äì191) that retains the fat-burning properties of growth hormone without affecting blood sugar or IGF-1 levels. An FDA-approved anti-obesity drug in some markets.',
    mechanism: 'AOD-9604 mimics the way endogenous HGH regulates fat metabolism by stimulating lipolysis (fat breakdown) and inhibiting lipogenesis (fat storage). Unlike full HGH, it does not affect insulin-like growth factor (IGF-1) levels or carbohydrate metabolism, eliminating many HGH side effects while preserving its fat-loss benefits.',
    benefits: [
      'Targeted fat reduction without systemic HGH effects',
      'Stimulates lipolysis (fat breakdown)',
      'Inhibits fat storage (lipogenesis)',
      'No effect on blood sugar or insulin',
      'No effect on IGF-1',
      'Prevents diet-induced obesity in animal models',
    ],
    side_effects: [
      'Mild headaches',
      'Indigestion',
      'Injection site flushing or swelling',
      'Mild nausea',
    ],
    dosage_info: {
      min_dose: 250,
      max_dose: 500,
      unit: 'mcg',
      frequency: 'Once daily, on an empty stomach',
      notes: 'Most effective when taken fasted. 20-day research cycles.',
      weight_based: false,
    },
    cycle_length: '20 days',
    stack_with: ['cjc-1295', 'ipamorelin', 'semaglutide'],
    research_status: 'research_only',
    administration_routes: ['subcutaneous injection', 'oral'],
    molecular_formula: 'C78H123N23O23S2',
    half_life: 'Short (minutes)',
  },
  {
    name: '5-Amino-1MQ',
    slug: '5-amino-1mq',
    aliases: ['5-Amino-1-methylquinolinium', '5A1MQ', '5-Amino-1MQ'],
    category_slug: 'weight-management',
    summary: 'A small molecule inhibitor of NNMT (nicotinamide N-methyltransferase) enzyme that boosts metabolism and promotes fat cell apoptosis. Shows promise as a novel anti-obesity agent in preclinical research.',
    mechanism: 'NNMT is an enzyme that suppresses the metabolic rate and promotes fat storage. 5-Amino-1MQ blocks NNMT, which increases the NAD+/NADH ratio, activates SIRT1, and upregulates metabolic pathways. In animal studies, this leads to significant reductions in fat cell size and body weight without changes in diet.',
    benefits: [
      'Inhibits NNMT to boost resting metabolic rate',
      'Promotes fat cell shrinkage and apoptosis',
      'Increases NAD+ levels',
      'Potential for muscle sparing during weight loss',
      'Weight loss without diet changes in animal studies',
    ],
    side_effects: [
      'Limited human data available',
      'Potential GI discomfort',
    ],
    dosage_info: {
      min_dose: 50,
      max_dose: 100,
      unit: 'mg',
      frequency: 'Once or twice daily oral',
      notes: 'Research compound with limited human clinical data. Exercise caution.',
      weight_based: false,
    },
    cycle_length: '4‚Äì8 weeks',
    stack_with: ['semaglutide', 'aod-9604'],
    research_status: 'research_only',
    administration_routes: ['oral'],
    molecular_formula: 'C10H12N2',
    half_life: null,
  },
  {
    name: 'Retatrutide',
    slug: 'retatrutide',
    aliases: ['LY3437943'],
    category_slug: 'weight-management',
    summary: 'An emerging triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Phase 3 clinical trials show unprecedented weight loss of up to 24% body weight, making it potentially the most powerful weight loss peptide in development.',
    mechanism: 'Retatrutide acts simultaneously on three receptors: GLP-1 (appetite suppression, glucose control), GIP (incretin effect, fat oxidation), and glucagon (energy expenditure, hepatic fat mobilization). This triple agonism creates synergistic metabolic effects exceeding dual agonists like tirzepatide.',
    benefits: [
      'Up to 24% body weight reduction in Phase 2 trials',
      'Triple receptor agonism (GLP-1 + GIP + glucagon)',
      'Superior to tirzepatide in early comparisons',
      'Significant improvements in metabolic biomarkers',
      'Weekly dosing',
    ],
    side_effects: [
      'Nausea, vomiting, diarrhea',
      'Constipation',
      'Decreased appetite',
      'Currently only clinical trial data available',
    ],
    dosage_info: {
      min_dose: 1,
      max_dose: 12,
      unit: 'mg',
      frequency: 'Once weekly subcutaneous injection',
      notes: 'Not yet approved ‚Äî Phase 3 clinical trials ongoing as of 2025.',
      weight_based: false,
    },
    cycle_length: 'Ongoing / chronic',
    stack_with: [],
    research_status: 'clinical_trials',
    administration_routes: ['subcutaneous injection'],
    molecular_formula: null,
    half_life: ''
  },
  {
    name: 'MOTS-C',
    slug: 'mots-c',
    aliases: ['Mitochondrial Open Reading Frame of the 12S rRNA-c'],
    category_slug: 'weight-management',
    summary: 'A mitochondria-derived peptide encoded in the 12S rRNA gene that acts as a metabolic regulator, improving insulin sensitivity, exercise capacity, and potentially mimicking caloric restriction.',
    mechanism: 'MOTS-C is a 16-amino acid peptide produced by mitochondria that activates the AMPK pathway in skeletal muscle, improving glucose uptake and fatty acid oxidation. It also reduces insulin resistance and has been shown to extend lifespan in aging mouse models.',
    benefits: [
      'Improves insulin sensitivity',
      'Increases metabolic flexibility',
      'Enhances exercise performance and endurance',
      'Anti-aging and longevity potential',
      'Reduces metabolic syndrome markers',
      'May mimic caloric restriction effects',
    ],
    side_effects: [
      'Limited human data',
      'Injection site reactions',
    ],
    dosage_info: {
      min_dose: 5,
      max_dose: 10,
      unit: 'mg',
      frequency: '3‚Äì5x per week, subcutaneous or intramuscular',
      notes: 'Research peptide with promising but limited human data.',
      weight_based: false,
    },
    cycle_length: '8‚Äì12 weeks',
    stack_with: ['epithalon', 'ghk-cu'],
    research_status: 'research_only',
    administration_routes: ['subcutaneous injection', 'intramuscular injection'],
    molecular_formula: 'C92H152N28O30S',
    half_life: null,
  },

  // HEALING & RECOVERY
  {
    name: 'BPC-157',
    slug: 'bpc-157',
    aliases: ['Body Protection Compound-157', 'BPC157', 'Pentadecapeptide', 'PL 14736'],
    category_slug: 'healing-recovery',
    summary: 'A 15-amino acid peptide fragment derived from a protective protein found in gastric juice. Remarkably effective at accelerating healing of tendons, ligaments, muscles, and gut tissue. One of the most studied healing peptides.',
    mechanism: 'BPC-157 promotes healing through multiple mechanisms: stimulating VEGF (vascular endothelial growth factor) for angiogenesis, activating growth hormone receptors in tendon fibroblasts, upregulating growth factor expression, and modulating the nitric oxide system. It accelerates the regeneration of virtually every tissue type it has been tested on.',
    benefits: [
      'Accelerated tendon and ligament healing',
      'Muscle repair and regeneration',
      'Reduced inflammation',
      'Gut health and intestinal healing (Crohn\'s disease research)',
      'Liver protection and regeneration',
      'Neuroprotection and brain injury recovery',
      'Reduced pain at injury sites',
      'Protection against NSAID-induced damage',
    ],
    side_effects: [
      'Generally very well tolerated',
      'Mild nausea (oral route)',
      'Injection site discomfort',
      'Theoretically may accelerate existing tumors (unconfirmed)',
    ],
    dosage_info: {
      min_dose: 1,
      max_dose: 10,
      unit: 'mcg/kg',
      frequency: 'Once or twice daily',
      notes: 'Can be administered orally for gut issues. Inject near injury site for localized healing. Typical daily dose: 200‚Äì500mcg total.',
      weight_based: true,
    },
    cycle_length: '4‚Äì12 weeks',
    stack_with: ['tb-500', 'igf-1-lr3', 'ghk-cu'],
    research_status: 'research_only',
    administration_routes: ['subcutaneous injection', 'oral', 'topical'],
    molecular_formula: 'C62H98N16O22',
    half_life: '4 hours (estimated)',
  },
  {
    name: 'TB-500',
    slug: 'tb-500',
    aliases: ['Thymosin Beta-4', 'TŒ≤4', 'TB500', 'LKKTETQ'],
    category_slug: 'healing-recovery',
    summary: 'A synthetic version of Thymosin Beta-4, a naturally occurring 43-amino acid protein present in nearly all human cells. Promotes cellular healing, anti-inflammation, and tissue regeneration throughout the entire body.',
    mechanism: 'TB-500 upregulates actin, a protein essential for cell building and movement. By increasing the availability of actin, TB-500 promotes cell migration, proliferation, and differentiation. It also stimulates angiogenesis, reduces inflammation through cytokine modulation, and exhibits systemic healing properties unlike localized peptides.',
    benefits: [
      'Systemic healing and tissue repair',
      'Accelerated recovery from injury (muscles, tendons, ligaments)',
      'Anti-inflammatory effects',
      'Improved flexibility and joint mobility',
      'Hair growth stimulation',
      'Neurological recovery',
      'Cardiovascular tissue repair',
      'Enhanced endurance',
    ],
    side_effects: [
      'Mild headaches',
      'Lethargy immediately after injection',
      'Nausea',
      'Injection site pain',
      'Potential tumor growth concern (theoretical, unconfirmed)',
    ],
    dosage_info: {
      min_dose: 5,
      max_dose: 20,
      unit: 'mg',
      frequency: '2x per week loading phase, then 1x per week maintenance',
      notes: 'Loading phase: 4‚Äì6 weeks at higher dose. Maintenance: 2‚Äì6mg weekly. Stack with BPC-157 for synergistic healing.',
      weight_based: false,
    },
    cycle_length: '4‚Äì6 weeks (loading), ongoing maintenance',
    stack_with: ['bpc-157', 'igf-1-lr3', 'ghk-cu'],
    research_status: 'research_only',
    administration_routes: ['subcutaneous injection', 'intramuscular injection'],
    molecular_formula: 'C212H350N56O78S',
    half_life: null,
  },
  {
    name: 'ARA-290',
    slug: 'ara-290',
    aliases: ['Cibinetide', 'ARA290', 'MIMETIBODY'],
    category_slug: 'healing-recovery',
    summary: 'A synthetic 11-amino acid peptide that mimics the tissue-protective actions of erythropoietin (EPO) without its erythropoietic (blood cell production) effects. Highly effective for neuropathic pain and nerve repair.',
    mechanism: 'ARA-290 acts on the innate repair receptor (IRR), a receptor complex present on tissues undergoing stress or damage. Unlike erythropoietin, it does not bind the classical EPO receptor (which drives red blood cell production). It reduces nerve-level inflammation, promotes nerve fiber regeneration, and rapidly penetrates the CNS.',
    benefits: [
      'Reduces neuropathic pain significantly',
      'Promotes peripheral nerve regeneration',
      'Reduces nerve inflammation',
      'Penetrates the blood-brain barrier',
      'No erythropoietic (blood-thickening) effects',
      'Investigated for traumatic brain injury, sarcoidosis',
    ],
    side_effects: [
      'Headache',
      'Injection site reactions',
      'Potential blood pressure changes',
    ],
    dosage_info: {
      min_dose: 4,
      max_dose: 8,
      unit: 'mg',
      frequency: 'Once daily subcutaneous injection',
      notes: '4-week cycles studied in clinical trials for neuropathic pain.',
      weight_based: false,
    },
    cycle_length: '4 weeks',
    stack_with: ['bpc-157', 'tb-500'],
    research_status: 'clinical_trials',
    administration_routes: ['subcutaneous injection'],
    molecular_formula: 'C49H79N17O14S',
    half_life: null,
  },
  {
    name: 'GHK-Cu',
    slug: 'ghk-cu',
    aliases: ['GHK-Copper', 'Copper Peptide', 'Copper Tripeptide-1', 'GHK'],
    category_slug: 'anti-aging',
    summary: 'A naturally occurring copper-binding tripeptide found in human plasma, saliva, and urine that declines with age. Promotes skin rejuvenation, wound healing, hair growth, and anti-inflammatory effects. One of the most studied anti-aging peptides.',
    mechanism: 'GHK-Cu activates copper-dependent enzymes involved in collagen and elastin synthesis, promotes wound healing by stimulating VEGF and FGF, activates stem cells in hair follicles, and modulates a vast number of genes involved in tissue remodeling. It resets genes related to aging back toward a younger expression pattern.',
    benefits: [
      'Stimulates collagen and elastin production',
      'Reduces fine lines and wrinkles',
      'Accelerates wound healing',
      'Promotes hair growth and reduces hair loss',
      'Anti-inflammatory and antioxidant',
      'Potential anti-cancer properties (modulates growth factors)',
      'Skin tightening and rejuvenation',
      'Activates over 4,000 human genes',
    ],
    side_effects: [
      'Topical: mild skin irritation initially',
      'Injectable: injection site reactions',
      'Very well tolerated overall',
    ],
    dosage_info: {
      min_dose: 1,
      max_dose: 3,
      unit: 'mg',
      frequency: 'Daily topical application or 1‚Äì3x per week injectable',
      notes: 'Available in topical creams/serums and injectable form. Both routes are effective.',
      weight_based: false,
    },
    cycle_length: 'Ongoing',
    stack_with: ['bpc-157', 'tb-500', 'epithalon'],
    research_status: 'research_only',
    administration_routes: ['topical', 'subcutaneous injection'],
    molecular_formula: 'C14H24CuN6O4',
    half_life: null,
  },

  // ANTI-AGING
  {
    name: 'Epithalon',
    slug: 'epithalon',
    aliases: ['Epitalon', 'Epithalone', 'Ala-Glu-Asp-Gly'],
    category_slug: 'anti-aging',
    summary: 'A synthetic tetrapeptide (Ala-Glu-Asp-Gly) that activates telomerase, the enzyme responsible for lengthening telomeres. One of the only compounds with robust evidence for telomere extension in humans. Developed by Dr. Vladimir Khavinson at the St. Petersburg Institute of Bioregulation.',
    mechanism: 'Epithalon stimulates the pineal gland to regulate melatonin, activates telomerase to maintain and extend telomere length, and modulates the expression of genes involved in aging and longevity. A 12-year longitudinal study showed 28% lower mortality in subjects treated with an epithalamin precursor.',
    benefits: [
      'Activates telomerase and extends telomere length',
      'Potential longevity and anti-aging effects',
      'Improves sleep quality via melatonin regulation',
      'Antioxidant properties',
      'Immune function enhancement',
      'Potential anti-cancer effects',
      'Improved mood and reduced anxiety',
      'Normalization of gonadotropin levels',
    ],
    side_effects: [
      'Mild nausea',
      'Stomach discomfort',
      'Generally very well tolerated',
    ],
    dosage_info: {
      min_dose: 5,
      max_dose: 10,
      unit: 'mg',
      frequency: 'Once daily subcutaneous or intramuscular injection',
      notes: 'Typical cycle: 10‚Äì20 days, 1‚Äì2x per year. Can also be administered nasally or under tongue.',
      weight_based: false,
    },
    cycle_length: '10‚Äì20 days, 1‚Äì2x per year',
    stack_with: ['ghk-cu', 'thymosin-alpha-1', 'mots-c'],
    research_status: 'research_only',
    administration_routes: ['subcutaneous injection', 'intramuscular injection', 'intranasal'],
    molecular_formula: 'C14H22N4O9',
    half_life: null,
  },
  {
    name: 'Vilon',
    slug: 'vilon',
    aliases: ['Lys-Glu', 'Vilon dipeptide'],
    category_slug: 'anti-aging',
    summary: 'A synthetic dipeptide (Lys-Glu) from the Khavinson bioregulator series developed at the St. Petersburg Institute. Primarily acts as a thymus and immune regulator with demonstrated anti-aging properties in clinical studies.',
    mechanism: 'Vilon activates thymus-dependent immune functions by stimulating T-lymphocyte differentiation and proliferation. It normalizes immune function that declines with age and has been shown to extend lifespan in animal models through immunomodulation.',
    benefits: [
      'Immune system normalization and enhancement',
      'Anti-aging via immune modulation',
      'Thymus gland support',
      'Potential lifespan extension (animal studies)',
      'Stress response modulation',
    ],
    side_effects: [
      'Very well tolerated',
      'Minimal reported side effects',
    ],
    dosage_info: {
      min_dose: 1,
      max_dose: 2,
      unit: 'mg',
      frequency: 'Daily injection for 10-day cycle courses',
      notes: 'Part of the Khavinson peptide bioregulator series. Often combined with Epithalon.',
      weight_based: false,
    },
    cycle_length: '10-day courses, 2x per year',
    stack_with: ['epithalon', 'thymosin-alpha-1'],
    research_status: 'research_only',
    administration_routes: ['subcutaneous injection'],
    molecular_formula: 'C12H24N4O5',
    half_life: null,
  },
  {
    name: 'Vesugen',
    slug: 'vesugen',
    aliases: ['Lys-Glu-Asp', 'Vascular Peptide'],
    category_slug: 'anti-aging',
    summary: 'A synthetic tripeptide from the Khavinson bioregulator series designed to support vascular health and blood vessel integrity. Studied for cardiovascular aging and vascular disease prevention.',
    mechanism: 'Vesugen is a vascular tissue-specific peptide bioregulator that normalizes the function of blood vessel walls by promoting endothelial cell regeneration and reducing oxidative damage to vascular tissue.',
    benefits: [
      'Supports blood vessel wall integrity',
      'Cardiovascular health and aging',
      'Endothelial cell function improvement',
      'Potential reduction in vascular disease progression',
    ],
    side_effects: [
      'Minimal reported side effects',
      'Well tolerated',
    ],
    dosage_info: {
      min_dose: 1,
      max_dose: 2,
      unit: 'mg',
      frequency: 'Daily for 10-day courses',
      notes: 'Khavinson series peptide bioregulator. Best used in combination protocols.',
      weight_based: false,
    },
    cycle_length: '10-day courses, 2x per year',
    stack_with: ['epithalon', 'ghk-cu'],
    research_status: 'research_only',
    administration_routes: ['subcutaneous injection'],
    molecular_formula: null,
    half_life: null,
  },

  // TANNING
  {
    name: 'Melanotan 1',
    slug: 'melanotan-1',
    aliases: ['MT-1', 'Afamelanotide', 'CUV1647'],
    category_slug: 'tanning',
    summary: 'A synthetic analog of alpha-MSH (melanocyte-stimulating hormone) that stimulates melanin production for skin tanning. The more selective of the two Melanotan variants, with FDA-orphan drug status for erythropoietic protoporphyria.',
    mechanism: 'Melanotan 1 selectively activates MC1R (melanocortin 1 receptor) on melanocytes, stimulating melanin production (melanogenesis) without activating sexual arousal pathways. A subcutaneous implant form (Scenesse) is FDA/EMA-approved for erythropoietic protoporphyria to reduce phototoxicity.',
    benefits: [
      'Promotes skin tanning without UV exposure',
      'FDA-approved form for erythropoietic protoporphyria',
      'Reduces UV-induced skin damage',
      'More selective than Melanotan 2',
      'Lower sexual arousal side effects than MT-2',
    ],
    side_effects: [
      'Nausea (especially with initial doses)',
      'Flushing',
      'Fatigue',
      'Mild libido changes (less than MT-2)',
      'Injection site reactions',
      'New moles or darkening of existing moles',
    ],
    dosage_info: {
      min_dose: 500,
      max_dose: 1000,
      unit: 'mcg',
      frequency: 'Loading: daily; Maintenance: 2‚Äì3x per week',
      notes: 'Start with low doses to assess tolerance. Sunlight exposure enhances the tanning effect.',
      weight_based: false,
    },
    cycle_length: '4‚Äì8 weeks loading, maintenance ongoing',
    stack_with: ['melanotan-2'],
    research_status: 'prescription',
    administration_routes: ['subcutaneous injection'],
    molecular_formula: 'C78H111N21O19',
    half_life: '1‚Äì1.5 hours',
  },
  {
    name: 'Melanotan 2',
    slug: 'melanotan-2',
    aliases: ['MT-2', 'Melanotan II'],
    category_slug: 'tanning',
    summary: 'A broader-acting melanocortin peptide that stimulates both melanin production and the sexual arousal pathway. Produces potent tanning effects and is also used for erectile dysfunction and female sexual dysfunction.',
    mechanism: 'Melanotan 2 is a cyclic 7-amino acid analog of alpha-MSH that activates multiple melanocortin receptors (MC1R for pigmentation, MC3R and MC4R for sexual arousal and appetite suppression). Its broader receptor profile compared to MT-1 results in more pronounced sexual side effects alongside tanning.',
    benefits: [
      'Strong melanin production and skin tanning',
      'Libido enhancement and sexual arousal',
      'Appetite suppression (moderate)',
      'Erectile dysfunction support',
      'Fat loss (modest, via appetite suppression)',
    ],
    side_effects: [
      'Nausea (significant, especially at start)',
      'Spontaneous erections (males)',
      'Facial flushing',
      'Fatigue',
      'Yawning',
      'Potential kidney damage at high doses',
      'New moles or melanoma risk (unconfirmed but theoretical)',
    ],
    dosage_info: {
      min_dose: 250,
      max_dose: 500,
      unit: 'mcg',
      frequency: 'Daily loading, then 2‚Äì3x per week maintenance',
      notes: 'Start with 250mcg to assess nausea tolerance. Higher doses not recommended. Sunlight amplifies tanning.',
      weight_based: false,
    },
    cycle_length: '4‚Äì8 weeks loading',
    stack_with: ['pt-141'],
    research_status: 'research_only',
    administration_routes: ['subcutaneous injection', 'intranasal'],
    molecular_formula: 'C50H69N15O9',
    half_life: '30‚Äì60 minutes',
  },

  // COGNITIVE
  {
    name: 'Semax',
    slug: 'semax',
    aliases: ['N-Acetyl Semax', 'MEHFPGP', 'ACTH 4-10'],
    category_slug: 'cognitive',
    summary: 'A synthetic heptapeptide derived from ACTH 4-7 that significantly boosts BDNF (brain-derived neurotrophic factor) levels. Widely used in Russia for cognitive enhancement, stroke recovery, and neurological conditions.',
    mechanism: 'Semax increases BDNF, NGF (nerve growth factor), and enkephalins in the brain, promoting neuroplasticity and neuroprotection. It modulates the dopaminergic and serotonergic systems and exhibits anti-inflammatory properties in brain tissue. N-Acetyl Semax Amidate is the more bioavailable modified version.',
    benefits: [
      'Significantly increases BDNF levels',
      'Improves memory, focus, and learning',
      'Anxiolytic (reduces anxiety)',
      'Neuroprotective effects',
      'Studied for ADHD, depression, and brain injury recovery',
      'Stroke rehabilitation support',
      'Mood enhancement',
    ],
    side_effects: [
      'Mild nasal irritation (intranasal route)',
      'Headaches',
      'Temporary fatigue',
      'Irritability with high doses',
    ],
    dosage_info: {
      min_dose: 250,
      max_dose: 1000,
      unit: 'mcg',
      frequency: 'Once or twice daily via nasal spray',
      notes: 'N-Acetyl Semax Amidate is the most potent form. Start with low dose to assess tolerance.',
      weight_based: false,
    },
    cycle_length: '2‚Äì4 weeks on, 1‚Äì2 weeks off',
    stack_with: ['selank', 'epithalon'],
    research_status: 'prescription',
    administration_routes: ['intranasal'],
    molecular_formula: 'C37H51N9O10S',
    half_life: 'Minutes (active in brain)',
  },
  {
    name: 'Selank',
    slug: 'selank',
    aliases: ['N-Acetyl Selank', 'Tuftsin Analog', 'TP-7'],
    category_slug: 'cognitive',
    summary: 'A synthetic heptapeptide derived from tuftsin that exhibits anxiolytic, nootropic, and immunomodulatory effects. Considered a milder, anxiolytic counterpart to Semax with a strong safety profile.',
    mechanism: 'Selank modulates GABA-A receptors, serotonin, and enkephalin systems to produce anxiolytic effects. It also regulates the expression of BDNF and is immunomodulatory via IL-6 and interferon modulation. Unlike benzodiazepines, it does not cause dependence or significant sedation.',
    benefits: [
      'Potent anxiolytic without sedation or dependence',
      'Improves mood and emotional stability',
      'Cognitive enhancement (focus, memory)',
      'Immunomodulatory properties',
      'Neuroprotective',
      'Reduces stress response',
    ],
    side_effects: [
      'Mild nasal irritation',
      'Mild headaches',
      'Slight fatigue initially',
      'Generally very well tolerated',
    ],
    dosage_info: {
      min_dose: 250,
      max_dose: 500,
      unit: 'mcg',
      frequency: 'Once or twice daily via nasal spray',
      notes: 'Can be stacked with Semax for complementary cognitive + anxiolytic effects.',
      weight_based: false,
    },
    cycle_length: '2‚Äì4 weeks',
    stack_with: ['semax', 'epithalon'],
    research_status: 'prescription',
    administration_routes: ['intranasal'],
    molecular_formula: 'C33H57N11O10',
    half_life: 'Minutes',
  },
  {
    name: 'Noopept',
    slug: 'noopept',
    aliases: ['GVS-111', 'N-phenylacetyl-L-prolylglycine ethyl ester', 'Omberacetam'],
    category_slug: 'cognitive',
    summary: 'A synthetic dipeptide nootropic approximately 1000x more potent than piracetam by weight. Stimulates BDNF and NGF expression and exhibits significant neuroprotective and cognitive-enhancing effects.',
    mechanism: 'Noopept enhances expression of BDNF and NGF in the hippocampus and other brain regions, promoting neuronal survival and neuroplasticity. It acts on AMPA receptors, modulates NMDA receptors, and has antioxidant and anti-apoptotic properties in neuronal tissue.',
    benefits: [
      'Memory and learning enhancement (especially consolidation)',
      'Increases BDNF and NGF',
      'Neuroprotective against excitotoxicity',
      'Reduces anxiety (at moderate doses)',
      'Very potent at low doses (cost-effective)',
      'Potential for Alzheimer\'s research',
    ],
    side_effects: [
      'Irritability and brain fog with high doses',
      'Headaches (choline supplementation may help)',
      'Mild fatigue',
      'Rarely: increased anxiety with high doses',
    ],
    dosage_info: {
      min_dose: 10,
      max_dose: 30,
      unit: 'mg',
      frequency: 'Once or twice daily, oral or sublingual',
      notes: 'Sublingual administration increases bioavailability. Stack with choline (Alpha-GPC or CDP-choline).',
      weight_based: false,
    },
    cycle_length: '56 days on, 4 weeks off',
    stack_with: ['semax', 'selank'],
    research_status: 'research_only',
    administration_routes: ['oral', 'sublingual', 'intranasal'],
    molecular_formula: 'C17H22N2O4',
    half_life: 'Minutes (but effects last hours)',
  },
  {
    name: 'Cerebrolysin',
    slug: 'cerebrolysin',
    aliases: ['FPF-1070'],
    category_slug: 'cognitive',
    summary: 'A complex mixture of low-molecular-weight neuropeptides derived from porcine brain proteins. The only peptide-based nootropic with robust clinical evidence for Alzheimer\'s disease, stroke recovery, and traumatic brain injury.',
    mechanism: 'Cerebrolysin contains multiple neuropeptides that mimic the action of endogenous neurotrophic factors including NGF, BDNF, CNTF, and GDNF. It promotes neurogenesis, synaptogenesis, and neurite growth while protecting against excitotoxicity, oxidative stress, and apoptosis.',
    benefits: [
      'Demonstrated efficacy in Alzheimer\'s disease trials',
      'Stroke rehabilitation support',
      'Traumatic brain injury recovery',
      'Memory and cognitive improvement',
      'Promotes neurogenesis and synaptogenesis',
      'Neuroprotection against multiple mechanisms',
    ],
    side_effects: [
      'Headaches',
      'Nausea and vomiting',
      'Dizziness',
      'Injection site pain',
      'Rare allergic reactions',
    ],
    dosage_info: {
      min_dose: 5,
      max_dose: 10,
      unit: 'mL',
      frequency: 'Daily intramuscular injection, 10‚Äì20 day courses',
      notes: 'Higher doses (20‚Äì30mL) used in clinical settings for brain injury. Start with 5mL.',
      weight_based: false,
    },
    cycle_length: '10‚Äì20 days',
    stack_with: ['semax', 'epithalon', 'noopept'],
    research_status: 'prescription',
    administration_routes: ['intramuscular injection', 'intravenous injection'],
    molecular_formula: null,
    half_life: null,
  },
  {
    name: 'DSIP (Delta Sleep Inducing Peptide)',
    slug: 'dsip',
    aliases: ['Delta Sleep Inducing Peptide', 'DSIP'],
    category_slug: 'cognitive',
    summary: 'A neuropeptide that promotes slow-wave (delta wave) sleep and modulates stress hormones. Used for sleep optimization, stress reduction, and recovery enhancement.',
    mechanism: 'DSIP induces slow-wave sleep by modulating neurotransmitter systems including serotonin, catecholamines, and GABA. It reduces cortisol and ACTH levels, modulates the stress response, and has antioxidant properties. Its exact receptors and full mechanism remain incompletely understood.',
    benefits: [
      'Promotes deep (delta wave) sleep',
      'Reduces cortisol and stress hormone levels',
      'Improves sleep quality and duration',
      'Antioxidant properties',
      'Recovery enhancement',
      'Potential for treating insomnia and stress disorders',
    ],
    side_effects: [
      'Mild headaches',
      'Nausea',
      'Generally well tolerated at low doses',
    ],
    dosage_info: {
      min_dose: 100,
      max_dose: 500,
      unit: 'mcg',
      frequency: 'Once daily, before sleep',
      notes: 'Research compound with limited clinical data. Start with low doses.',
      weight_based: false,
    },
    cycle_length: '4‚Äì8 weeks',
    stack_with: ['epithalon', 'selank'],
    research_status: 'research_only',
    administration_routes: ['subcutaneous injection'],
    molecular_formula: 'C35H48N10O15',
    half_life: null,
  },

  // IMMUNE SUPPORT
  {
    name: 'Thymosin Alpha-1',
    slug: 'thymosin-alpha-1',
    aliases: ['TŒ±1', 'Thymalfasin', 'Zadaxin'],
    category_slug: 'immune-support',
    summary: 'A 28-amino acid peptide naturally produced by the thymus gland that modulates both innate and adaptive immunity. FDA-approved under the name Zadaxin in some countries for hepatitis B, hepatitis C, and as a vaccine adjuvant.',
    mechanism: 'Thymosin Alpha-1 augments T-cell maturation and activation, increases NK cell activity, promotes dendritic cell differentiation, and modulates cytokine production. It corrects immune deficiencies associated with aging, chronic disease, and immunosuppressive therapy.',
    benefits: [
      'Boosts adaptive and innate immunity',
      'Antiviral and antibacterial properties',
      'Approved for hepatitis B and C in multiple countries',
      'Cancer immunotherapy adjuvant',
      'Effective as vaccine adjuvant',
      'Anti-aging through immune optimization',
      'Reduced susceptibility to infections',
    ],
    side_effects: [
      'Injection site redness and swelling',
      'Mild fatigue',
      'Generally very well tolerated',
    ],
    dosage_info: {
      min_dose: 0.8,
      max_dose: 6.4,
      unit: 'mg',
      frequency: '2‚Äì3x per week subcutaneous injection',
      notes: 'Clinical dose: 1.6mg twice weekly. Can be run for months. Common in integrative medicine.',
      weight_based: false,
    },
    cycle_length: '6‚Äì12 weeks',
    stack_with: ['epithalon', 'bpc-157', 'ghk-cu'],
    research_status: 'prescription',
    administration_routes: ['subcutaneous injection'],
    molecular_formula: 'C129H215N33O55',
    half_life: '2 hours',
  },
  {
    name: 'LL-37',
    slug: 'll-37',
    aliases: ['Cathelicidin', 'hCAP18/LL-37', 'CAMP'],
    category_slug: 'immune-support',
    summary: 'The only human cathelicidin antimicrobial peptide, naturally produced by immune cells and epithelial cells as a first-line defense. Has broad-spectrum antimicrobial, wound healing, and immunomodulatory properties.',
    mechanism: 'LL-37 disrupts bacterial, fungal, and viral cell membranes through direct membrane permeabilization. It also acts as an immunomodulator by binding to TLR receptors, modulating the inflammatory cascade, attracting immune cells to infection sites, and promoting wound healing through growth factor signaling.',
    benefits: [
      'Broad-spectrum antimicrobial (bacteria, fungi, viruses)',
      'Innate immune defense',
      'Wound healing acceleration',
      'Anti-inflammatory in chronic conditions',
      'Potential anti-tumor properties',
      'First-line defense against infections',
    ],
    side_effects: [
      'Injection site irritation',
      'Limited long-term human data',
      'Paradoxically pro-inflammatory in some contexts',
    ],
    dosage_info: {
      min_dose: 100,
      max_dose: 500,
      unit: 'mcg',
      frequency: 'Daily to 3x weekly',
      notes: 'Research compound. Topical formulations used for skin infections.',
      weight_based: false,
    },
    cycle_length: '4‚Äì8 weeks',
    stack_with: ['thymosin-alpha-1', 'bpc-157'],
    research_status: 'research_only',
    administration_routes: ['subcutaneous injection', 'topical'],
    molecular_formula: null,
    half_life: null,
  },

  // SEXUAL HEALTH
  {
    name: 'PT-141 (Bremelanotide)',
    slug: 'pt-141',
    aliases: ['Bremelanotide', 'PT141', 'Vyleesi'],
    category_slug: 'sexual-health',
    summary: 'An FDA-approved melanocortin agonist for hypoactive sexual desire disorder (HSDD) in premenopausal women. Acts centrally via the CNS to increase sexual desire and arousal in both men and women.',
    mechanism: 'PT-141 is derived from Melanotan 2 and activates MC3R and MC4R receptors in the hypothalamus and limbic system of the brain, increasing sexual desire and arousal through central nervous system mechanisms rather than vascular effects. This distinguishes it from PDE5 inhibitors like Viagra.',
    benefits: [
      'Increases sexual desire and arousal in men and women',
      'FDA-approved for HSDD in premenopausal women (Vyleesi)',
      'Treats erectile dysfunction through novel CNS mechanism',
      'Works in individuals who don\'t respond to PDE5 inhibitors',
      'Acts centrally (brain) not peripherally (blood vessels)',
    ],
    side_effects: [
      'Nausea (most common)',
      'Flushing',
      'Headache',
      'Transient blood pressure increases',
      'Spontaneous erections (males)',
    ],
    dosage_info: {
      min_dose: 1,
      max_dose: 2,
      unit: 'mg',
      frequency: 'As needed, 45‚Äì90 minutes before sexual activity',
      notes: 'FDA-approved dose: 1.75mg subcutaneous. No more than once per 24 hours or 8x per month.',
      weight_based: false,
    },
    cycle_length: 'As needed',
    stack_with: ['kisspeptin-10', 'melanotan-2'],
    research_status: 'fda_approved',
    administration_routes: ['subcutaneous injection', 'intranasal'],
    molecular_formula: 'C50H68N14O10',
    half_life: '2 hours',
  },
  {
    name: 'Kisspeptin-10',
    slug: 'kisspeptin-10',
    aliases: ['Metastin 45-54', 'Kisspeptin 10', 'KP-10'],
    category_slug: 'sexual-health',
    summary: 'A 10-amino acid neuropeptide that acts as the master regulator of the reproductive hormonal axis by stimulating GnRH release. Supports testosterone, libido, fertility, and sexual health in both men and women.',
    mechanism: 'Kisspeptin-10 binds to the KISS1R receptor on GnRH neurons in the hypothalamus, triggering pulsatile GnRH release which drives downstream LH, FSH, testosterone, and estrogen production. It is the primary upstream regulator of the hypothalamic-pituitary-gonadal (HPG) axis.',
    benefits: [
      'Stimulates GnRH and downstream testosterone/estrogen',
      'Increases sexual arousal and motivation',
      'Supports fertility (LH and FSH stimulation)',
      'Improves hormonal balance',
      'Used in TRT protocols to maintain testicular function',
      'Improves mood and wellbeing via hormonal normalization',
    ],
    side_effects: [
      'Mild nausea',
      'Headache',
      'Flushing',
    ],
    dosage_info: {
      min_dose: 10,
      max_dose: 100,
      unit: 'mcg',
      frequency: 'Pulse dosing 2‚Äì3x weekly',
      notes: 'Continuous administration can desensitize KISS1R. Use pulsatile dosing protocol.',
      weight_based: false,
    },
    cycle_length: '4‚Äì8 weeks',
    stack_with: ['pt-141', 'gonadorelin'],
    research_status: 'research_only',
    administration_routes: ['subcutaneous injection', 'intranasal'],
    molecular_formula: 'C63H87N15O14',
    half_life: '28 minutes',
  },
  {
    name: 'Gonadorelin',
    slug: 'gonadorelin',
    aliases: ['GnRH', 'Gonadotropin-Releasing Hormone', 'LHRH', 'Factrel'],
    category_slug: 'sexual-health',
    summary: 'A synthetic form of endogenous GnRH that stimulates the pituitary to release LH and FSH. Widely used in TRT protocols to maintain testicular size and function and prevent secondary hypogonadism.',
    mechanism: 'Gonadorelin binds GnRH receptors on pituitary gonadotroph cells, stimulating pulsatile release of LH and FSH. LH drives Leydig cell testosterone production in men; FSH supports spermatogenesis. It maintains HPG axis function during exogenous testosterone use.',
    benefits: [
      'Maintains testicular volume during TRT',
      'Prevents secondary hypogonadism from exogenous testosterone',
      'Preserves fertility during testosterone use',
      'Diagnostic tool for GnRH deficiency',
      'Supports post-cycle recovery',
    ],
    side_effects: [
      'Injection site reactions',
      'Flushing',
      'Nausea',
      'Headache',
      'Tachyphylaxis with continuous administration',
    ],
    dosage_info: {
      min_dose: 100,
      max_dose: 250,
      unit: 'mcg',
      frequency: '2‚Äì3x weekly, subcutaneous injection',
      notes: 'Must be dosed pulsatilely (not continuously) to avoid desensitization of pituitary receptors.',
      weight_based: false,
    },
    cycle_length: 'Concurrent with TRT or ongoing',
    stack_with: ['kisspeptin-10', 'pt-141'],
    research_status: 'prescription',
    administration_routes: ['subcutaneous injection'],
    molecular_formula: 'C55H75N17O13',
    half_life: '2‚Äì4 minutes',
  },
  {
    name: 'HMG (Human Menopausal Gonadotropin)',
    slug: 'hmg',
    aliases: ['Human Menopausal Gonadotropin', 'Menopur', 'Menogon'],
    category_slug: 'sexual-health',
    summary: 'A urinary-derived combination of LH and FSH used clinically for fertility treatment and in bodybuilding/TRT protocols for testicular stimulation and spermatogenesis support.',
    mechanism: 'HMG contains both FSH (follicle-stimulating hormone) and LH (luteinizing hormone). In men, LH stimulates Leydig cells to produce testosterone while FSH directly supports spermatogenesis and Sertoli cell function. This dual action makes it superior to hCG alone for fertility preservation.',
    benefits: [
      'Stimulates both testosterone production and spermatogenesis',
      'Fertility support in men on TRT',
      'Testicular volume maintenance',
      'Combined LH and FSH activity',
      'Superior to hCG for sperm production support',
    ],
    side_effects: [
      'Injection site reactions',
      'Gynecomastia risk',
      'Ovarian hyperstimulation in women',
      'Mood changes',
    ],
    dosage_info: {
      min_dose: 75,
      max_dose: 150,
      unit: 'IU',
      frequency: '3x weekly subcutaneous injection',
      notes: 'Used in fertility medicine and TRT protocols. Requires medical supervision.',
      weight_based: false,
    },
    cycle_length: '4‚Äì12 weeks',
    stack_with: ['gonadorelin', 'kisspeptin-10'],
    research_status: 'prescription',
    administration_routes: ['subcutaneous injection', 'intramuscular injection'],
    molecular_formula: null,
    half_life: '24‚Äì36 hours',
  },

  // EXPERIMENTAL
  {
    name: 'Adipotide (FTPP)',
    slug: 'adipotide',
    aliases: ['FTPP', 'Proapoptotic Peptide', 'Adipose-Targeted Proapoptotic Peptide'],
    category_slug: 'experimental',
    summary: 'A highly experimental proapoptotic peptide that selectively destroys the blood supply to white adipose tissue, causing dramatic fat loss in animal models. Considered one of the most powerful but most dangerous fat loss compounds under research.',
    mechanism: 'Adipotide consists of a targeting sequence (CKGGRAKDC) that homes to vasculature surrounding white adipose tissue, coupled to a proapoptotic sequence (KLAKLAK) that destroys mitochondria in targeted cells. By cutting off blood supply to fat cells, it causes programmed death of adipocytes.',
    benefits: [
      'Dramatic and rapid fat reduction in animal models',
      'Highly targeted to adipose tissue',
      'Theoretically no dietary changes required',
    ],
    side_effects: [
      'Significant renal toxicity (kidney damage) ‚Äî most serious concern',
      'Dehydration',
      'Reduced kidney function',
      'Limited human data ‚Äî potentially dangerous',
      'NOT recommended for human use',
    ],
    dosage_info: {
      min_dose: null,
      max_dose: null,
      unit: 'mcg/kg',
      frequency: 'Research only ‚Äî no established human protocol',
      notes: 'CAUTION: Significant renal toxicity observed in primates. Not for human use. Research compound only.',
      weight_based: true,
    },
    cycle_length: 'Research only',
    stack_with: [],
    research_status: 'research_only',
    administration_routes: ['subcutaneous injection'],
    molecular_formula: null,
    half_life: null,
  },
  {
    name: 'Macimorelin',
    slug: 'macimorelin',
    aliases: ['AEZS-130', 'Ghrelin Mimetic', 'Macrilen'],
    category_slug: 'experimental',
    summary: 'An orally active ghrelin receptor agonist FDA-approved as a diagnostic test for adult growth hormone deficiency. Provides a convenient oral GH stimulation test alternative to injectable provocative agents.',
    mechanism: 'Macimorelin is a synthetic growth hormone secretagogue that activates ghrelin receptors (GHS-R1a) in the pituitary and hypothalamus, stimulating GH release. Unlike other GH secretagogues used off-label, Macimorelin is FDA-approved specifically for diagnosing GH deficiency in adults.',
    benefits: [
      'FDA-approved diagnostic for adult GH deficiency',
      'Oral administration (no injection required for testing)',
      'Reliable GH stimulation for diagnostic purposes',
      'Investigated for therapeutic GH deficiency treatment',
    ],
    side_effects: [
      'Nausea',
      'Headache',
      'Dysgeusia (taste disturbance)',
      'Dizziness',
      'Fatigue',
    ],
    dosage_info: {
      min_dose: 0.5,
      max_dose: 0.5,
      unit: 'mg/kg',
      frequency: 'Single dose (diagnostic use)',
      notes: 'Diagnostic dose: 0.5mg/kg oral, single administration. Not established for therapeutic ongoing use.',
      weight_based: true,
    },
    cycle_length: 'Single dose (diagnostic)',
    stack_with: [],
    research_status: 'fda_approved',
    administration_routes: ['oral'],
    molecular_formula: 'C26H29FN4O3',
    half_life: '4 hours',
  },
]

export const SUPPLIERS = [
  {
    name: 'Swiss Chems',
    slug: 'swiss-chems',
    url: 'https://swisschems.is',
    has_coa: true,
    rating: 4.9,
    payment_methods: ['Credit Card', 'CashApp', 'Zelle', 'Bitcoin', 'Crypto'],
    ships_internationally: true,
    logo_url: null,
  },
  {
    name: 'Amino Asylum',
    slug: 'amino-asylum',
    url: 'https://aminoasylum.shop',
    has_coa: false,
    rating: 4.5,
    payment_methods: ['Credit Card (4% fee)', 'Zelle', 'CashApp', 'Venmo'],
    ships_internationally: false,
    logo_url: null,
  },
  {
    name: 'Limitless Life Nootropics',
    slug: 'limitless-life',
    url: 'https://limitlesslifenootropics.com',
    has_coa: true,
    rating: 4.8,
    payment_methods: ['Credit Card', 'eCheck', 'Crypto (10% off)', 'Bank Transfer', 'CashApp'],
    ships_internationally: true,
    logo_url: null,
  },
  {
    name: 'Science.Bio',
    slug: 'science-bio',
    url: 'https://science.bio',
    has_coa: true,
    rating: 5.0,
    payment_methods: ['Crypto (5% off)', 'eCheck', 'Debit Card', 'Credit Card (10% fee)'],
    ships_internationally: false,
    logo_url: null,
  },
  {
    name: 'Pure Rawz',
    slug: 'pure-rawz',
    url: 'https://purerawz.co',
    has_coa: true,
    rating: 4.6,
    payment_methods: ['Credit Card', 'Crypto', 'PayPal', 'Check'],
    ships_internationally: true,
    logo_url: null,
  },
  {
    name: 'ResearchChemical.com',
    slug: 'research-chemical',
    url: 'https://researchchemical.com',
    has_coa: true,
    rating: 4.8,
    payment_methods: ['Credit Card', 'Check'],
    ships_internationally: false,
    logo_url: null,
  },
  {
    name: 'Core Peptides',
    slug: 'core-peptides',
    url: 'https://corepeptides.com',
    has_coa: true,
    rating: 4.8,
    payment_methods: ['Credit Card', 'Venmo', 'Zelle', 'CashApp'],
    ships_internationally: false,
    logo_url: null,
  },
  {
    name: 'Spectre Labs',
    slug: 'spectre-labs',
    url: 'https://spectrelabs.co',
    has_coa: true,
    rating: 4.5,
    payment_methods: ['Credit Card', 'Crypto', 'Apple Pay', 'Debit Card', 'Zelle', 'Bank Transfer'],
    ships_internationally: true,
    logo_url: null,
  },
]

export const STACKS = [
  {
    name: 'Classic GH Stack',
    slug: 'classic-gh-stack',
    description: 'The most popular peptide stack for muscle growth and body recomposition. CJC-1295 provides sustained GHRH stimulation while Ipamorelin adds selective GH pulses without cortisol elevation.',
    peptides: ['cjc-1295', 'ipamorelin'],
    goal: 'Muscle growth, fat loss, body recomposition',
    protocol: 'CJC-1295: 300mcg 3x weekly + Ipamorelin: 200‚Äì300mcg daily before bed. Run for 8‚Äì12 weeks.',
  },
  {
    name: 'Ultimate Healing Stack',
    slug: 'healing-stack',
    description: 'BPC-157 and TB-500 are highly complementary ‚Äî BPC-157 works locally for tissue repair while TB-500 works systemically. Together they cover both acute and chronic injury healing.',
    peptides: ['bpc-157', 'tb-500'],
    goal: 'Injury recovery, tissue repair, anti-inflammation',
    protocol: 'BPC-157: 250‚Äì500mcg twice daily near injury site + TB-500: 5mg 2x per week. Run for 4‚Äì6 weeks.',
  },
  {
    name: 'Anti-Aging Protocol',
    slug: 'anti-aging-protocol',
    description: 'A comprehensive anti-aging stack combining telomere support (Epithalon), skin/tissue regeneration (GHK-Cu), and immune optimization (Thymosin Alpha-1).',
    peptides: ['epithalon', 'ghk-cu', 'thymosin-alpha-1'],
    goal: 'Anti-aging, longevity, immune optimization',
    protocol: 'Epithalon: 5‚Äì10mg daily for 10‚Äì20 days (2x/year). GHK-Cu: Topical daily + 1‚Äì3mg injectable 2x/week ongoing. Thymosin Alpha-1: 1.6mg 2x/week for 6 weeks.',
  },
  {
    name: 'Cognitive Enhancement Stack',
    slug: 'cognitive-stack',
    description: 'Semax and Selank complement each other perfectly ‚Äî Semax provides stimulating cognitive enhancement and BDNF upregulation while Selank provides anxiolytic balance and emotional stability.',
    peptides: ['semax', 'selank'],
    goal: 'Cognitive enhancement, anxiety reduction, focus',
    protocol: 'Semax: 300‚Äì600mcg nasal spray in the morning. Selank: 250‚Äì500mcg nasal spray in the afternoon or as needed for anxiety. 2‚Äì4 week cycles.',
  },
  {
    name: 'Weight Loss Stack',
    slug: 'weight-loss-stack',
    description: 'Semaglutide provides powerful appetite suppression and metabolic benefits while AOD-9604 directly targets fat metabolism through GH fragment activity ‚Äî complementary mechanisms.',
    peptides: ['semaglutide', 'aod-9604'],
    goal: 'Fat loss, appetite suppression, metabolic optimization',
    protocol: 'Semaglutide: Start 0.25mg weekly, titrate up. AOD-9604: 250‚Äì500mcg daily on empty stomach. Monitor blood glucose.',
  },
  {
    name: 'Muscle Building Power Stack',
    slug: 'muscle-building-stack',
    description: 'Combines upstream GH stimulation (CJC-1295 + Ipamorelin) with direct muscle-building action (IGF-1 LR3) for maximum anabolic effect. Advanced stack ‚Äî not for beginners.',
    peptides: ['cjc-1295', 'ipamorelin', 'igf-1-lr3'],
    goal: 'Maximum muscle growth and strength',
    protocol: 'CJC-1295 + Ipamorelin as foundation. Add IGF-1 LR3: 40‚Äì80mcg post-workout. Always take with carbohydrates. 4‚Äì6 week cycles with breaks.',
  },
]
